Advertisement
Review Article| Volume 25, ISSUE 2, P305-316, June 2005

Clear Cell Renal Cell Carcinoma

      In 2003, there were an estimated 35,000 new cases and 12,480 deaths in the United States attributed to tumors of the kidney and ureter [
      • Jemal A.
      • Tiwari R.C.
      • Murray T.
      • et al.
      Cancer statistics, 2004.
      ]; of these, approximately 75% are renal cell carcinoma (RCC) [
      • Lynch C.F.
      • Cohen M.B.
      Urinary system.
      ]. The bulk of the literature in RCC reflects clear cell RCC because it accounts for approximately 70% of all adult epithelial kidney tumors in surgically resected series [
      • Thoenes W.
      • Störkel S.
      • Rumpelt H.J.
      Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas).
      ]. The incidence seems to be increasing [
      • Chow W.H.
      • Devesa S.S.
      • Warren J.L.
      • et al.
      Rising incidence of renal cell cancer in the United States.
      ]. Most cases occur in adults who are older than 40 years of age, although no age group—including children—is spared [
      • Leuschner I.
      • Harms D.
      • Schmidt D.
      Renal cell carcinoma in children: histology, immunohistochemistry and follow-up of 10 cases.
      ]. There is a male preponderance with approximately a 1.5:1 ratio [
      • Jemal A.
      • Tiwari R.C.
      • Murray T.
      • et al.
      Cancer statistics, 2004.
      ]. There is a higher incidence among blacks than among whites in North America [
      • Chow W.H.
      • Devesa S.S.
      • Warren J.L.
      • et al.
      Rising incidence of renal cell cancer in the United States.
      ]. Outside of the major hereditary disorders (von Hippel-Lindau (VHL) disease, tuberous sclerosis), smoking is considered to be the single most important risk factor for the development of RCC [
      • La Vecchia C.
      • Negri E.
      • D'Avanzo B.
      • et al.
      Smoking and renal cell carcinoma.
      ,
      • McLaughlin J.K.
      • Mandel J.S.
      • Blot W.J.
      • et al.
      A population-based case-control study of renal cell carcinoma.
      ,
      • Moyad M.A.
      Review of potential risk factors for kidney (renal cell) cancer.
      ]. Other factors that are linked to RCC include obesity, particularly in women [
      • Wynder E.L.
      • Mabuchi K.
      • Whitmore Jr., W.F.
      Epidemiology of adenocarcinoma of the kidney.
      ,
      • Maclure M.
      • Willett W.
      A case-control study of diet and risk of renal adenocarcinoma.
      ,
      • Moyad M.A.
      Obesity interrelated mechanisms, and exposures and kidney cancer.
      ], and a variety of chemical agents [
      • Kolonel L.N.
      Association of cadmium with renal cancer.
      ,
      • McLaughlin J.K.
      • Blot W.J.
      • Mehl E.S.
      • et al.
      Petroleum-related employment and renal cell cancer.
      ,
      • Sharpe C.R.
      • Rochon J.E.
      • Adam J.M.
      • et al.
      Case-control study of hydrocarbon exposures in patients with renal cell carcinoma.
      ]. Although long-term phenacetin and acetaminophen use has been linked to renal cell carcinoma, the former is associated much more strongly with transitional cell carcinoma of the renal pelvis [
      • Lindblad P.
      • McLaughlin J.K.
      • Mellemgaard A.
      • et al.
      Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study.
      ]. RCC has been reported in association with AIDS [
      • Azon-Masoliver A.
      • Moreno A.
      • Gatell J.M.
      • et al.
      Renal cell adenocarcinoma associated with AIDS-related Kaposi's sarcoma.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jemal A.
        • Tiwari R.C.
        • Murray T.
        • et al.
        Cancer statistics, 2004.
        CA Cancer J Clin. 2004; 54: 8-29
        • Lynch C.F.
        • Cohen M.B.
        Urinary system.
        Cancer. 1995; 75: 316-329
        • Thoenes W.
        • Störkel S.
        • Rumpelt H.J.
        Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas).
        Path Res Pract. 1986; 181: 125-143
        • Chow W.H.
        • Devesa S.S.
        • Warren J.L.
        • et al.
        Rising incidence of renal cell cancer in the United States.
        JAMA. 1999; 281: 1628-1631
        • Leuschner I.
        • Harms D.
        • Schmidt D.
        Renal cell carcinoma in children: histology, immunohistochemistry and follow-up of 10 cases.
        Med Pediatr Oncol. 1991; 19: 33-41
        • La Vecchia C.
        • Negri E.
        • D'Avanzo B.
        • et al.
        Smoking and renal cell carcinoma.
        Cancer Res. 1990; 50: 5231-5233
        • McLaughlin J.K.
        • Mandel J.S.
        • Blot W.J.
        • et al.
        A population-based case-control study of renal cell carcinoma.
        J Natl Cancer Inst. 1984; 72: 275-284
        • Moyad M.A.
        Review of potential risk factors for kidney (renal cell) cancer.
        Semin Urol Oncol. 2001; 19: 280-293
        • Wynder E.L.
        • Mabuchi K.
        • Whitmore Jr., W.F.
        Epidemiology of adenocarcinoma of the kidney.
        J Natl Cancer Inst. 1974; 53: 1619-1634
        • Maclure M.
        • Willett W.
        A case-control study of diet and risk of renal adenocarcinoma.
        Epidemiology. 1990; 1: 430-440
        • Moyad M.A.
        Obesity interrelated mechanisms, and exposures and kidney cancer.
        Semin Urol Oncol. 2001; 19: 270-279
        • Kolonel L.N.
        Association of cadmium with renal cancer.
        Cancer. 1976; 37: 1782-1787
        • McLaughlin J.K.
        • Blot W.J.
        • Mehl E.S.
        • et al.
        Petroleum-related employment and renal cell cancer.
        J Occup Med. 1985; 27: 672-674
        • Sharpe C.R.
        • Rochon J.E.
        • Adam J.M.
        • et al.
        Case-control study of hydrocarbon exposures in patients with renal cell carcinoma.
        CMAJ. 1989; 140: 1309-1318
        • Lindblad P.
        • McLaughlin J.K.
        • Mellemgaard A.
        • et al.
        Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study.
        Int J Cancer. 1993; 55: 5-59
        • Azon-Masoliver A.
        • Moreno A.
        • Gatell J.M.
        • et al.
        Renal cell adenocarcinoma associated with AIDS-related Kaposi's sarcoma.
        AIDS. 1990; 4: 818-819
        • Yoshida S.O.
        • Imam A.
        • Olson C.A.
        • et al.
        Proximal renal tubular surface membrane antigens identified in primary and metastatic renal cell carcinomas.
        Arch Pathol Lab Med. 1986; 110: 825-832
        • Wallace A.
        • Nairn R.C.
        Renal tubular antigens in kidney tumors.
        Cancer. 1972; 29: 977-981
        • Murphy W.M.
        • Grignon D.J.
        • Perlman E.
        Tumors of the kidney, bladder, and related urinary structures, 4th series.
        Armed Forces Institute of Pathology, Washington, DC2004
      1. Eble J.N. Sauter G. Epstein J.I. World Health Organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyons (France)2004
        • Kovacs G.
        • Szucs S.
        • De Reise W.
        • et al.
        Specific chromosome aberration in human renal cell carcinoma.
        Int J Cancer. 1987; 40: 171-178
        • Yoshida M.A.
        • Ohyashiki K.
        • Ochi H.
        • et al.
        Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
        Cancer Res. 1986; 46: 2139-2147
        • Anglard P.
        • Troy K.
        • Brauch H.
        • et al.
        Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
        Cancer Res. 1991; 51: 1071-1077
        • Whaley J.M.
        • Naglich J.
        • Gelbert L.
        • et al.
        Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
        Am J Hum Genet. 1994; 55: 1092-1102
        • Goodman M.D.
        • Goodman B.K.
        • Lubin M.B.
        • et al.
        Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome.
        Cancer. 1990; 65: 1150-1154
        • Latif F.
        • Tory K.
        • Gnarra J.
        • et al.
        Identification of the von Hippel–Lindau disease tumor suppressor gene.
        Science. 1993; 260: 1317-1320
        • Takahashi M.
        • Kahnoski R.
        • Gross D.
        • et al.
        Familial adult renal neoplasia.
        J Med Genet. 2002; 39: 1-5
        • Sukosd F.
        • Kuroda N.
        • Beothe T.
        • et al.
        Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
        Cancer Res. 2003; 63: 455-457
        • Srigley J.R.
        • Hutter R.V.P.
        • Gelb A.B.
        • et al.
        Current prognostic factors—renal cell carcinoma.
        Cancer. 1997; 80: 994-996
        • Gelb A.B.
        Renal cell carcinoma: current prognostic factors.
        Cancer. 1997; 80: 981-986
        • Amin M.B.
        • Amin M.B.
        • Tamboli P.
        • et al.
        Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases.
        Am J Surg Pathol. 2002; 26: 281-291
        • Cheville J.C.
        • Lohse C.M.
        • Zincke H.
        • et al.
        Comparison of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
        Am J Surg Pathol. 2003; 27: 612-624
        • Kattan M.W.
        • Reuter V.
        • Motzer R.J.
        • et al.
        A postoperative prognostic nomogram for renal cell carcinoma.
        J Urol. 2001; 166: 63-67
        • Lam J.S.
        • Shvarts O.
        • Pantuck A.
        Changing concepts in the surgical management of renal cell carcinoma.
        Eur Urol. 2004; 45: 692-705
        • Fergany A.
        • Hafez K.S.
        • Novick A.C.
        Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.
        J Urol. 2000; 163: 442-445
        • Huland E.
        • Heinzer H.
        Renal cell carcinoma—innovative medical treatments.
        Curr Opin Urol. 2004; 14: 239-244
        • Smith S.J.
        • Bosniak M.A.
        • Megibow A.J.
        • et al.
        Renal cell carcinoma: earlier discovery and increased detection.
        Radiology. 1989; 170: 699-703
        • Hartman D.S.
        • Davis Jr., C.J.
        • Johns T.
        • et al.
        Cystic renal cell carcinoma.
        Urology. 1986; 28: 145-153
        • Fukuoka T.
        • Honda M.
        • Namiki M.
        • et al.
        Renal cell carcinoma with heterotopic bone formation: case report and review of the literature.
        Urol Int. 1987; 42: 458-460
        • Cheng W.S.
        • Farrow G.M.
        • Zincke H.
        The incidence of multicentricity in renal cell carcinoma.
        J Urol. 1991; 146: 1221-1223
        • Kletscher B.A.
        • Qian J.
        • Bostwick D.G.
        • et al.
        Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume, and deoxyribonucleic acid ploidy.
        J Urol. 1995; 153: 904-906
        • Oya M.
        • Nakamura K.
        • Baba S.
        • et al.
        Intrarenal satellites of renal cell carcinoma: histopathologic manifestation and clinical implication.
        Urology. 1995; 46: 161-164
        • Murphy W.M.
        • Beckwith J.B.
        • Farrow G.M.
        Tumors of the kidney, bladder, and related structures.
        3rd edition. Armed Forces Institute of Pathology, Washington, DC1994
        • Jimenez R.E.
        • Eble J.N.
        • Reuter V.E.
        • et al.
        Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases.
        Mod Pathol. 2001; 14: 157-163
        • Horton W.A.
        • Wong V.
        • Eldridge R.
        von Hippel-Lindau disease, clinical and pathological manifestations in nine families with 50 affected members.
        Arch Intern Med. 1976; 136: 769-777
        • Wegner H.E.H.
        • Bornhoft G.
        • Dieckmann K.-P.
        Renal cell cancer and concomitant transitional cell cancer of the renal pelvis and ureter in the same kidney: report of 4 cases and review of the literature.
        Urol Int. 1993; 51: 158-163
        • Weeks D.A.
        • Beckwith J.B.
        • Mierau G.W.
        • et al.
        Renal neoplasms mimicking rhabdoid tumor of kidney: a report from the National Wilms' Tumor Study Pathology Center.
        Am J Surg Pathol. 1991; 15: 1042-1054
        • Gokden N.
        • Nappi O.
        • Swanson P.E.
        • et al.
        Renal cell carcinoma with rhabdoid features.
        Am J Surg Pathol. 2000; 24: 1329-1338
        • Shannon B.A.
        • Cohen R.J.
        Rhabdoid differentiation of chromophobe renal cell carcinoma.
        Pathology. 2003; 35: 228-230
        • Jagirdar J.
        • Irie T.
        • French S.W.
        • et al.
        Globular mallory-like bodies in renal cell carcinoma: report of a case and review of cytoplasmic eosinophilic globules.
        Hum Pathol. 1985; 16: 949-952
        • Datta B.N.
        Hyaline intracytoplasmic globules in renal carcinoma.
        Arch Pathol Lab Med. 1977; 101 ([letter]): 391
        • Hull M.T.
        • Eble J.N.
        Myelinoid lamellated cytoplasmic inclusions in human renal adenocarcinomas: an ultrastructural study.
        Ultrastruc Pathol. 1988; 12: 41-48
        • de Peralta-Venturina M.
        • Moch H.
        • Amin M.
        • et al.
        Sarcomatoid differentiation in renal cell carcinoma; a study of 101 cases.
        Am J Surg Pathol. 2001; 25: 275-284
        • Moder K.G.
        • Litin S.C.
        • Gaffey T.A.
        Renal cell carcinoma associated with sarcoidlike tissue reaction.
        Mayo Clin Proc. 1990; 65: 1498-1501
        • Fuhrman S.A.
        • Lasky L.C.
        • Limas C.
        Prognostic significance of morphologic parameters in renal cell carcinoma.
        Am J Surg Pathol. 1982; 6: 655-663
        • Ruiz-Cerda J.L.
        • Hernandez M.
        • Gomis F.
        • et al.
        Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
        J Urol. 1996; 155: 459-465
        • Grignon D.J.
        • Ayala A.G.
        • El-Naggar A.K.
        • et al.
        Renal cell carcinoma: a clinicopathologic and DNA flow cytometric analysis of 103 cases.
        Cancer. 1989; 64: 2133-2140
        • Lohse C.M.
        • Blute M.L.
        • Zincke H.
        • et al.
        Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients.
        Am J Clin Pathol. 2002; 118: 877-886
        • Green L.K.
        • Ayala A.G.
        • Ro J.Y.
        • et al.
        Role of nuclear grading in stage I renal cell carcinoma.
        Urology. 1989; 34: 310-315
        • Gelb A.B.
        • Shibuya R.B.
        • Weiss L.M.
        • et al.
        Stage I renal cell carcinoma: a clinicopathologic study of 82 cases.
        Am J Surg Pathol. 1993; 17: 275-286
        • El-Naggar A.K.
        • Ro J.Y.
        • Ensigen L.G.
        Papillary renal cell carcinoma: clinical implication of DNA content analysis.
        Hum Pathol. 1993; 24: 316-321
        • Eble J.N.
        • Bonsib S.M.
        Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma and cystic hamartoma of the renal pelvis.
        Semin Diagn Pathol. 1998; 15: 2-20
        • Murad T.
        • Komaiko W.
        • Oyasu R.
        • et al.
        Multilocular cystic renal cell carcinoma.
        Am J Clin Pathol. 1991; 95: 633-637
        • Nassir A.
        • Jollimore J.
        • Gupta R.
        • et al.
        Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature.
        Urol. 2002; 60: 421-427
        • Grignon D.J.
        • Bismar T.A.
        • Bianco F.
        • et al.
        VHL gene mutations in multilocular cystic renal cell carcinoma: evidence in support of its classification as a type of clear cell renal cell carcinoma.
        Mod Pathol. 2004; 17 ([abstract]): 154A
        • Cajulis R.S.
        • Katz R.L.
        • Dekmezian R.H.
        • et al.
        Fine needle aspiration biopsy of renal cell carcinoma: cytologic parameters and their concordance with histology and flow cytometric data.
        Acta Cytol. 1993; 37: 367-372
        • Renshaw A.A.
        • Lee K.R.
        • Madge R.
        • et al.
        Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma.
        Acta Cytol. 1997; 41: 987-994
        • Pitz S.
        • Moll R.
        • Störkel S.
        • et al.
        Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas: distinction of two classes of renal cell tumors.
        Lab Invest. 1987; 56: 642-653
        • Cao Y.
        • Karsten U.
        • Zerban H.
        • et al.
        Expression of MUC1, Thomas-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions.
        Virchows Arch. 2000; 436: 119-126
        • Medeiros L.J.
        • Michie S.A.
        • Johnson D.E.
        • et al.
        An immunoperoxidase study of renal cell carcinoma: correlation with nuclear grade, cell type, and histologic pattern.
        Hum Pathol. 1988; 19: 980-987
        • Ordonez N.G.
        The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
        Hum Pathol. 2004; 35: 697-710
        • Chu P.G.
        • Weiss L.M.
        Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases.
        Histopathol. 2001; 39: 455-462
        • McGregor D.K.
        • Khurana K.K.
        • Cao C.
        • et al.
        Diagnosing primary and metastatic renal cell carcinoma. The use of the monoclonal antibody “renal cell carcinoma marker”.
        Am J Surg Pathol. 2001; 25: 1485-1492
        • Fleming S.
        • Lindop G.B.M.
        • Gibson A.A.M.
        The distribution of epithelial membrane antigen in the kidney and its tumors.
        Histopathology. 1985; 9: 729-739
        • Avery A.K.
        • Beckstead J.
        • Renshaw A.A.
        Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
        Am J Surg Pathol. 2000; 24: 203-210
        • Kim M.K.
        • Kim S.
        Immunohistochemical profile of common epithelial neoplasms arising in the kidney.
        Appl Immunohistochem Mol Morphol. 2002; 10: 332-338
        • Shah I.A.
        • Mellstrom M.
        • Wheeler L.
        • et al.
        CD 68 immunoreactivity in renal cell carcinoma: an aid to diagnosis and histogenesis.
        J Urol Pathol. 1996; 5: 193-206
        • Coffin C.M.
        • Swanson P.E.
        • Wick M.R.
        • et al.
        An immunohistochemical comparison of chordoma with renal cell carcinoma, colorectal adenocarcinoma, and myxopapillary ependymoma: a potential diagnostic dilemma in the diminutive biopsy.
        Mod Pathol. 1993; 6: 531-538
        • Poulakis V.
        • Witzsch U.
        • de Vries R.
        • et al.
        Alpha-fetoprotein producing renal cell carcinoma.
        Urol Int. 2001; 67: 181-183
        • Saito S.
        • Hatano T.
        • Kayakawa M.
        • et al.
        Studies on alpha-fetoprotein produced by renal cell carcinoma.
        Cancer. 1989; 63: 544-549
        • Young A.N.
        • de Oliveira Salles G.
        • Lim S.D.
        • et al.
        Beta defensin-1 parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays.
        Am J Surg Pathol. 2003; 27: 199-205
        • Tickoo S.K.
        • Amin M.B.
        • Zarbo R.J.
        Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma. Emphasis on technique and patterns of staining.
        Am J Surg Pathol. 1998; 22: 419-424
        • Tickoo S.K.
        • Lee M.W.
        • Eble J.N.
        • et al.
        Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma.
        Am J Surg Pathol. 2000; 24: 1247-1256
        • Argani P.
        • Antonescu C.R.
        • Couturier J.
        • et al.
        PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural and molecular analysis of an entity associated with the t(X;1) (p11.2;q21).
        Am J Surg Pathol. 2002; 26: 1553-1566